The BIOFLOW-III Italian Satellite Registry: 18-month results of the Orsiro stent in an all-comer high-risk population
Conclusions
The study results confirmed the excellent clinical performance of the Orsiro drug-eluting stents at 18 months in the whole all-comer population and in the prespecified high-risk subgroups.
Source: Journal of Cardiovascular Medicine - Category: Cardiology Tags: Research articles: Interventional cardiology. Coronary artery disease Source Type: research
More News: Cardiology | Cardiovascular | Coronary Artery Bypass Graft | Diabetes | Endocrinology | Heart | Heart Attack | Italy Health | Study | Thrombosis